{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:28:59Z","timestamp":1791332939692,"version":"4.3.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T00:00:00Z","timestamp":1491264000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s11481-017-9740-y","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T21:46:44Z","timestamp":1491342404000},"page":"504-520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["HTLV-1 Infection and Neuropathogenesis in the Context of Rag1-\/-\u03b3c-\/- (RAG1-Hu) and BLT Mice"],"prefix":"10.1007","volume":"12","author":[{"given":"Rashida","family":"Ginwala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafar K.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajinkya","family":"Pattekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glen M.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Corley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronak","family":"Loonawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreesha","family":"Sreedhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishomwa C.","family":"Ndhlovu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8057-7835","authenticated-orcid":false,"given":"Pooja","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"9740_CR1","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/infdis\/jiq153","volume":"203","author":"NH Abdelbary","year":"2011","unstructured":"Abdelbary NH, Abdullah HM, Matsuzaki T, Hayashi D, Tanaka Y, Takashima H, Izumo S, Kubota R (2011) Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) tax-specific cytotoxic T lymphocytes in HTLV-I infection. J Infect Dis 203:948\u2013959","journal-title":"J Infect Dis"},{"key":"9740_CR2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020169","volume":"6","author":"R Akkina","year":"2011","unstructured":"Akkina R, Berges BK, Palmer BE, Remling L, Neff CP, Kuruvilla J, Connick E, Folkvord J, Gagliardi K, Kassu A, Akkina SR (2011) Humanized Rag1\u2212\/\u2212 gammac\u2212\/\u2212 mice support multilineage hematopoiesis and are susceptible to HIV-1 infection via systemic and vaginal routes. PLoS One 6:e20169","journal-title":"PLoS One"},{"key":"9740_CR3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003399","volume":"8","author":"CF Amorim","year":"2014","unstructured":"Amorim CF, Souza AS, Diniz AG, Carvalho NB, Santos SB, Carvalho EM (2014) Functional activity of monocytes and macrophages in HTLV-1 infected subjects. PLoS Negl Trop Dis 8:e3399","journal-title":"PLoS Negl Trop Dis"},{"key":"9740_CR4","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2009-10-246959","volume":"115","author":"P Banerjee","year":"2010","unstructured":"Banerjee P, Tripp A, Lairmore MD, Crawford L, Sieburg M, Ramos JC, Harrington W Jr, Beilke MA, Feuer G (2010) Adult T-cell leukemia\/lymphoma development in HTLV-1-infected humanized SCID mice. Blood 115:2640\u20132648","journal-title":"Blood"},{"key":"9740_CR5","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2008-06-163071","volume":"112","author":"CR Bangham","year":"2008","unstructured":"Bangham CR (2008) HTLV-1 infection: role of CTL efficiency. Blood 112:2176\u20132177","journal-title":"Blood"},{"key":"9740_CR6","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/eji.200939451","volume":"39","author":"CR Bangham","year":"2009","unstructured":"Bangham CR (2009) CTL quality and the control of human retroviral infections. Eur J Immunol 39:1700\u20131712","journal-title":"Eur J Immunol"},{"key":"9740_CR7","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.2741\/3420","volume":"14","author":"CR Bangham","year":"2009","unstructured":"Bangham CR, Meekings K, Toulza F, Nejmeddine M, Majorovits E, Asquith B, Taylor GP (2009) The immune control of HTLV-1 infection: selection forces and dynamics. Front Biosci (Landmark Ed) 14:2889\u20132903","journal-title":"Front Biosci (Landmark Ed)"},{"key":"9740_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0042-6822(02)00091-0","volume":"308","author":"K Barmak","year":"2003","unstructured":"Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B (2003) Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration. Virology 308:1\u201312","journal-title":"Virology"},{"key":"9740_CR9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-4690-3-76","volume":"3","author":"BK Berges","year":"2006","unstructured":"Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R (2006) HIV-1 infection and CD4 T cell depletion in the humanized Rag2\u2212\/\u2212gamma c\u2212\/\u2212 (RAG-hu) mouse model. Retrovirology 3:76\u201389","journal-title":"Retrovirology"},{"key":"9740_CR10","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.4049\/jimmunol.159.4.2018","volume":"159","author":"WE Biddison","year":"1997","unstructured":"Biddison WE, Kubota R, Kawanishi T, Taub DD, Cruikshank WW, Center DM, Connor EW, Utz U, Jacobson S (1997) Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase. J Immunol 159:2018\u20132025","journal-title":"J Immunol"},{"key":"9740_CR11","first-page":"341","volume":"20","author":"GS Brunetto","year":"2014","unstructured":"Brunetto GS, Massoud R, Leibovitch EC, Caruso B, Johnson K, Ohayon J, Fenton K, Cortese I, Jacobson S (2014) Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM\/TSP patients and identification of viral mutations. J Neuro-Oncol 20:341\u2013351","journal-title":"J Neuro-Oncol"},{"key":"9740_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.virusres.2011.08.014","volume":"163","author":"F Cabral","year":"2012","unstructured":"Cabral F, Arruda LB, de Araujo ML, Montanheiro P, Smid J, de Oliveira AC, Duarte AJ, Casseb J (2012) Detection of human T-cell lymphotropic virus type 1 in plasma samples. Virus Res 163:87\u201390","journal-title":"Virus Res"},{"key":"9740_CR13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13:227\u2013242","journal-title":"Nat Rev Immunol"},{"key":"9740_CR14","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1182\/blood-2012-07-445593","volume":"120","author":"LB Cook","year":"2012","unstructured":"Cook LB, Rowan AG, Melamed A, Taylor GP, Bangham CR (2012) HTLV-1-infected T cells contain a single integrated provirus in natural infection. Blood 120:3488\u20133490","journal-title":"Blood"},{"key":"9740_CR15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/1471-2334-14-453","volume":"14","author":"R Coutinho Jr","year":"2014","unstructured":"Coutinho R Jr, Grassi MF, Korngold AB, Olavarria VN, Galvao-Castro B, Mascarenhas RE (2014) Human T lymphotropic virus type 1 (HTLV-1) proviral load induces activation of T-lymphocytes in asymptomatic carriers. BMC Infect Dis 14:453","journal-title":"BMC Infect Dis"},{"key":"9740_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1182\/blood-2013-11-538272","volume":"123","author":"MD Dodon","year":"2014","unstructured":"Dodon MD (2014) Of mice, men, and HTLV-1. Blood 123:303\u2013304","journal-title":"Blood"},{"issue":"Suppl 2","key":"9740_CR17","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.1093\/infdis\/jit320","volume":"208","author":"TE Dudek","year":"2013","unstructured":"Dudek TE, Allen TM (2013) HIV-specific CD8+ T-cell immunity in humanized Bone marrow-liver-thymus mice. J Infect Dis 208(Suppl 2):S150\u2013S154","journal-title":"J Infect Dis"},{"key":"9740_CR18","doi-asserted-by":"crossref","first-page":"143ra198","DOI":"10.1126\/scitranslmed.3003984","volume":"4","author":"TE Dudek","year":"2012","unstructured":"Dudek TE, No DC, Seung E, Vrbanac VD, Fadda L, Bhoumik P, Boutwell CL, Power KA, Gladden AD, Battis L, Mellors EF, Tivey TR, Gao X, Altfeld M, Luster AD, Tager AM, Allen TM (2012) Rapid evolution of HIV-1 to functional CD8(+) T cell responses in humanized BLT mice. Sci Transl Med 4:143ra198","journal-title":"Sci Transl Med"},{"key":"9740_CR19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fimmu.2015.00310","volume":"6","author":"SA Fuertes Marraco","year":"2015","unstructured":"Fuertes Marraco SA, Neubert NJ, Verdeil G, Speiser DE (2015) Inhibitory receptors beyond T cell exhaustion. Front Immunol 6:310","journal-title":"Front Immunol"},{"key":"9740_CR20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lfs.2014.03.025","volume":"104","author":"HT Fuzii","year":"2014","unstructured":"Fuzii HT, da Silva Dias GA, de Barros RJ, Falcao LF, Quaresma JA (2014) Immunopathogenesis of HTLV-1-assoaciated myelopathy\/tropical spastic paraparesis (HAM\/TSP). Life Sci 104:9\u201314","journal-title":"Life Sci"},{"key":"9740_CR21","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.2353\/ajpath.2010.100536","volume":"177","author":"S Gorantla","year":"2010","unstructured":"Gorantla S, Makarov E, Finke-Dwyer J, Castanedo A, Holguin A, Gebhart CL, Gendelman HE, Poluektova L (2010) Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis. Am J Pathol 177:2938\u20132949","journal-title":"Am J Pathol"},{"key":"9740_CR22","first-page":"333","volume":"3","author":"HE Hajj","year":"2012","unstructured":"Hajj HE, Nasr R, Kfoury Y, Dassouki Z, Nasser R, Kchour G, Hermine O, de The H, Bazarbachi A (2012) Animal models on HTLV-1 and related viruses: what did we learn? Front Microbiol 3:333","journal-title":"Front Microbiol"},{"key":"9740_CR23","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1182\/blood.V95.4.1386.004k22_1386_1392","volume":"95","author":"E Hanon","year":"2000","unstructured":"Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CR (2000) Abundant tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95:1386\u20131392","journal-title":"Blood"},{"key":"9740_CR24","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","volume":"83","author":"BJ Hindson","year":"2011","unstructured":"Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, Makarewicz AJ, Bright IJ, Lucero MY, Hiddessen AL, Legler TC, Kitano TK, Hodel MR, Petersen JF, Wyatt PW, Steenblock ER, Shah PH, Bousse LJ, Troup CB, Mellen JC, Wittmann DK, Erndt NG, Cauley TH, Koehler RT, So AP, Dube S, Rose KA, Montesclaros L, Wang S, Stumbo DP, Hodges SP, Romine S, Milanovich FP, White HE, Regan JF, Karlin-Neumann GA, Hindson CM, Saxonov S, Colston BW (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83:8604\u20138610","journal-title":"Anal Chem"},{"key":"9740_CR25","doi-asserted-by":"crossref","unstructured":"Hyun J, Ramos JC, Toomey N, Balachandran S, Lavorgna A, Harhaj E, Barber GN (2015) Oncogenic HTLV-1 tax suppression of primary innate immune signaling pathways. J Virol 89:4880\u20134893","DOI":"10.1128\/JVI.02493-14"},{"key":"9740_CR26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/cmi.2012.2","volume":"9","author":"R Ito","year":"2012","unstructured":"Ito R, Takahashi T, Katano I, Ito M (2012) Current advances in humanized mouse models. Cell Mol Immunol 9:208\u2013214","journal-title":"Cell Mol Immunol"},{"key":"9740_CR27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1440-1789.2010.01135.x","volume":"30","author":"S Izumo","year":"2010","unstructured":"Izumo S (2010) Neuropathology of HTLV-1-associated myelopathy (HAM\/TSP): the 50th anniversary of Japanese society of Neuropathology. Neuropathology 30:480\u2013485","journal-title":"Neuropathology"},{"key":"9740_CR28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/348245a0","volume":"348","author":"S Jacobson","year":"1990","unstructured":"Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S (1990) Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245\u2013248","journal-title":"Nature"},{"key":"9740_CR29","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.humimm.2011.07.308","volume":"72","author":"T Kozako","year":"2011","unstructured":"Kozako T, Yoshimitsu M, Akimoto M, White Y, Matsushita K, Soeda S, Shimeno H, Kubota R, Izumo S, Arima N (2011) Programmed death-1 (PD-1)\/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy\/tropical spastic paraparesis and carriers with autoimmune disorders. Hum Immunol 72:1001\u20131006","journal-title":"Hum Immunol"},{"key":"9740_CR30","first-page":"53","volume":"8","author":"R Kubota","year":"2002","unstructured":"Kubota R, Soldan SS, Martin R, Jacobson S (2002) Selected cytotoxic T lymphocytes with high specificity for HTLV-I in cerebrospinal fluid from a HAM\/TSP patient. J Neuro-Oncol 8:53\u201357","journal-title":"J Neuro-Oncol"},{"key":"9740_CR31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-animal-022513-114117","volume":"2","author":"MD Lairmore","year":"2014","unstructured":"Lairmore MD (2014) Animal models of bovine leukemia virus and human T-lymphotrophic virus type-1: insights in transmission and pathogenesis. Annu Rev Anim Biosci 2:189\u2013208","journal-title":"Annu Rev Anim Biosci"},{"key":"9740_CR32","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1038\/sj.onc.1208974","volume":"24","author":"MD Lairmore","year":"2005","unstructured":"Lairmore MD, Silverman L, Ratner L (2005) Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 24:6005\u20136015","journal-title":"Oncogene"},{"key":"9740_CR33","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2005-11-4388","volume":"108","author":"P Lan","year":"2006","unstructured":"Lan P, Tonomura N, Shimizu A, Wang S, Yang YG (2006) Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus\/liver and CD34+ cell transplantation. Blood 108:487\u2013492","journal-title":"Blood"},{"key":"9740_CR34","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.4049\/jimmunol.176.4.2053","volume":"176","author":"N Legrand","year":"2006","unstructured":"Legrand N, Weijer K, Spits H (2006) Experimental models to study development and function of the human immune system in vivo. J Immunol 176:2053\u20132058","journal-title":"J Immunol"},{"key":"9740_CR35","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.2741\/3300","volume":"14","author":"V Lepoutre","year":"2009","unstructured":"Lepoutre V, Jain P, Quann K, Wigdahl B, Khan ZK (2009) Role of resident CNS cell populations in HTLV-1-associated neuroinflammatory disease. Front Biosci (Landmark Ed) 14:1152\u20131168","journal-title":"Front Biosci (Landmark Ed)"},{"key":"9740_CR36","first-page":"126","volume":"3","author":"MC Levin","year":"1997","unstructured":"Levin MC, Jacobson S (1997) HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system. J Neuro-Oncol 3:126\u2013140","journal-title":"J Neuro-Oncol"},{"key":"9740_CR37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nm0502-509","volume":"8","author":"MC Levin","year":"2002","unstructured":"Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC Jr, Hasty KA, Callaway JC, Zunt J, Desiderio D, Stuart JM (2002) Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med 8:509\u2013513","journal-title":"Nat Med"},{"key":"9740_CR38","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1038\/srep05290","volume":"4","author":"F Li","year":"2014","unstructured":"Li F, Cowley DO, Banner D, Holle E, Zhang L, Su L (2014) Efficient genetic manipulation of the NOD-Rag1\u2212\/\u2212IL2RgammaC-null mouse by combining in vitro fertilization and CRISPR\/Cas9 technology. Sci Rep 4:5290","journal-title":"Sci Rep"},{"key":"9740_CR39","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.24213","volume":"76","author":"W Liu","year":"2014","unstructured":"Liu W, Nair G, Vuolo L, Bakshi A, Massoud R, Reich DS, Jacobson S (2014) In vivo imaging of spinal cord atrophy in neuroinflammatory diseases. Ann Neurol 76:370\u2013378","journal-title":"Ann Neurol"},{"key":"9740_CR40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10875-013-9918-x","volume":"33","author":"SL Manuel","year":"2013","unstructured":"Manuel SL, Sehgal M, Connolly J, Makedonas G, Khan ZK, Gardner J, Betts MR, Jain P (2013a) Lack of recall response to tax in ATL and HAM\/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1. J Clin Immunol 33:1223\u20131239","journal-title":"J Clin Immunol"},{"key":"9740_CR41","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/aid.2013.0054","volume":"29","author":"SL Manuel","year":"2013","unstructured":"Manuel SL, Sehgal M, Khan ZK, Goedert JJ, Betts MR, Jain P (2013b) An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1. AIDS Res Hum Retrovir 29:1273\u20131285","journal-title":"AIDS Res Hum Retrovir"},{"key":"9740_CR42","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/nm1431","volume":"12","author":"MW Melkus","year":"2006","unstructured":"Melkus MW, Estes JD, Padgett-Thomas A, Gatlin J, Denton PW, Othieno FA, Wege AK, Haase AT, Garcia JV (2006) Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1. Nat Med 12:1316\u20131322","journal-title":"Nat Med"},{"key":"9740_CR43","first-page":"505","volume":"60","author":"O Morgan","year":"2011","unstructured":"Morgan O (2011) HTLV-1 associated myelopathy\/tropical spastic paraparesis: how far have we come? West Indian Med J 60:505\u2013512","journal-title":"West Indian Med J"},{"key":"9740_CR44","first-page":"228","volume":"9","author":"M Nagai","year":"2003","unstructured":"Nagai M, Osame M (2003) Human T-cell lymphotropic virus type I and neurological diseases. J Neuro-Oncol 9:228\u2013235","journal-title":"J Neuro-Oncol"},{"key":"9740_CR45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001030","volume":"5","author":"LC Ndhlovu","year":"2011","unstructured":"Ndhlovu LC, Leal FE, Hasenkrug AM, Jha AR, Carvalho KI, Eccles-James IG, Bruno FR, Vieira RG, York VA, Chew GM, Jones RB, Tanaka Y, Neto WK, Sanabani SS, Ostrowski MA, Segurado AC, Nixon DF, Kallas EG (2011) HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications. PLoS Negl Trop Dis 5:e1030","journal-title":"PLoS Negl Trop Dis"},{"key":"9740_CR46","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bjid.2012.06.022","volume":"16","author":"VN Olavarria","year":"2012","unstructured":"Olavarria VN, Gomes Ado N, Kruschewsky Rde A, Galvao-Castro B, Grassi MF (2012) Evolution of HTLV-1 proviral load in patients from Salvador, Brazil. Braz J Infect Dis 16:357\u2013360","journal-title":"Braz J Infect Dis"},{"key":"9740_CR47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cytogfr.2011.08.002","volume":"22","author":"S Oliere","year":"2011","unstructured":"Oliere S, Douville R, Sze A, Belgnaoui SM, Hiscott J (2011) Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis. Cytokine Growth Factor Rev 22:197\u2013210","journal-title":"Cytokine Growth Factor Rev"},{"key":"9740_CR48","first-page":"49","volume":"4","author":"AR Panfil","year":"2013","unstructured":"Panfil AR, Al-Saleem JJ, Green PL (2013) Animal models utilized in HTLV-1 research. Virology (Auckl) 4:49\u201359","journal-title":"Virology (Auckl)"},{"key":"9740_CR49","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/ac202578x","volume":"84","author":"LB Pinheiro","year":"2012","unstructured":"Pinheiro LB, Coleman VA, Hindson CM, Herrmann J, Hindson BJ, Bhat S, Emslie KR (2012) Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal Chem 84:1003\u20131011","journal-title":"Anal Chem"},{"key":"9740_CR50","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1172\/JCI44198","volume":"121","author":"J Publicover","year":"2011","unstructured":"Publicover J, Goodsell A, Nishimura S, Vilarinho S, Wang ZE, Avanesyan L, Spolski R, Leonard WJ, Cooper S, Baron JL (2011) IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest 121:1154\u20131162","journal-title":"J Clin Invest"},{"key":"9740_CR51","first-page":"259045","volume":"2012","author":"M Saito","year":"2012","unstructured":"Saito M, Bangham CR (2012) Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy\/tropical spastic paraparesis: recent perspectives. Leuk Res Treatment 2012:259045","journal-title":"Leuk Res Treatment"},{"key":"9740_CR52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077780","volume":"8","author":"E Seung","year":"2013","unstructured":"Seung E, Dudek TE, Allen TM, Freeman GJ, Luster AD, Tager AM (2013) PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads. PLoS One 8:e77780","journal-title":"PLoS One"},{"key":"9740_CR53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.1093933","volume":"304","author":"E Traggiai","year":"2004","unstructured":"Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304:104\u2013107","journal-title":"Science"},{"key":"9740_CR54","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.virol.2012.06.025","volume":"432","author":"M Veselinovic","year":"2012","unstructured":"Veselinovic M, Neff CP, Mulder LR, Akkina R (2012) Topical gel formulation of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 confers protection against HIV-1 vaginal challenge in a humanized mouse model. Virology 432:505\u2013510","journal-title":"Virology"},{"key":"9740_CR55","first-page":"531","volume":"17","author":"A Yari","year":"2014","unstructured":"Yari A, Rezaee SA, Valizadeh N, Rajaee T, Jazayeri SM, Soltani M, Norouzi M (2014) Evaluation of HTLV-1 activity in HAM\/TSP patients using proviral load and tax mRNA expression after in vitro lymphocyte activation. Iran J Basic Med Sci 17:531\u2013536","journal-title":"Iran J Basic Med Sci"},{"key":"9740_CR56","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1038\/sj.onc.1208981","volume":"24","author":"M Yoshida","year":"2005","unstructured":"Yoshida M (2005) Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24:5931\u20135937","journal-title":"Oncogene"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-017-9740-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-017-9740-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-017-9740-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T12:07:26Z","timestamp":1719144446000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-017-9740-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,4]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["9740"],"URL":"https:\/\/doi.org\/10.1007\/s11481-017-9740-y","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"value":"1557-1890","type":"print"},{"value":"1557-1904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,4]]}}}